BTG3 and nervous system disorder: When analysing chronic diseases individually, i.e., cardiovascular diseases, lung diseases, neurological diseases, Hashimoto’s disease, diabetes mellitus, there were no quantitative or qualitative changes with respect to ANA, anti-ENA, ACL, or anti-β2GPI antibodies.